During ViVE26, Panelists Express Enthusiasm for The Rural Health Transformation Program
Public health needs to function more as a muscle, one panelist says
Public health needs to function more as a muscle, one panelist says
Securities regulators say the role of Ipsen employee Dishant Gupta made him privy to details of the Epizyme acquisition. Gupta allegedly accumulated Epizyme shares while the deal was negotiated, then sold all of them hours after the transaction was announced. The post SEC Charges Ipsen Worker for Insider Trading Tied to $247M Epizyme Acquisition appeared…
Decenas de expertos en VIH de los Centros para el Control y Prevención de Enfermedades (CDC) recibieron correos electrónicos el miércoles 11 de junio revocando las notificaciones de despido recibidas diez semanas atrás. Sin embargo, el daño a sus proyectos podría ser permanente, y las restricciones continuas a sus investigaciones perjudicarán vidas, dijeron científicos de…
As online pharmacies have grown in prominence, the German government aim to pass legislation to increase the profits of brick-and-mortar pharmacies in order to keep more physical locations available to Germans. Did it move sales from online to brick-and-mortar pharmacies? Is the law likely to keep brick-and-mortar pharmacies in business? These are the questions asked…
At RSNA24, Eric Topol, M.D., gave his audience a glimpse into the future of medicine
The ability to reduce physician burnout is one of the most exciting things about AI, said CHAI CEO Brian Anderson. In his view, ambient listening AI could end up changing the healthcare delivery world in a similar way that the advent of the sewing machine changed the textile and fashion industry in the 1840s. The…
For the healthcare industry, this crisis isn’t just about financial risk — it’s about consumer trust. When patients can’t afford care, they disengage, often convinced the system isn’t built for them. And when trust erodes, so do outcomes — because people who don’t trust the system are less likely to seek care at all. The…
The choices we make now will determine not just the future of healthcare, but the kind of society we leave to our children. Will we continue to allow faceless algorithms to decide who lives and who suffers? Or will we finally reclaim healthcare’s moral center and build a system worthy of our highest values? The…
In November 2024, CMS finalized a 2.83% decrease in the physician fee schedule conversion factor, a key aspect of payment rates under the Medicare program, resulting in a 2.93% decrease in overall payments to physicians and other clinicians. Congress has not yet enacted legislation to address this payment cut, which went into effect on January…
GSK is acquiring Boston Pharmaceuticals’ efimosfermin, which posted Phase 2 results showing improvement in fibrosis and resolution of MASH. GSK said this fusion protein will complement an siRNA drug it is currently developing for liver diseases. The post GSK Makes a Big Liver Disease Move With $1.2B Deal for Phase 3-Ready MASH Drug appeared first…